Telix Pharmaceuticals Limited American Depositary Shares (TLX) Stock Price, Quote & AI Analysis

Live TLX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Telix Pharmaceuticals Limited American Depositary Shares.

TradeVae provides AI-driven analysis and real-time market intelligence for Telix Pharmaceuticals Limited American Depositary Shares (TLX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

T
TLX
Telix Pharmaceuticals Limited American Depositary Shares
real-time
$0.00 +0.00 (+0.00%)
Open
7.240000
High
7.440000
Low
7.240000
Volume
83,927
VWAP
-
Market Cap
$2,594,114,758.75
52W Range
$7.16 - $30.36
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Telix Pharmaceuticals Limited American Depositary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Telix Pharmaceuticals Limited American Depositary Shares Overview

Company information

Company Overview

Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.

Company Details
Market Cap
$2.56B
Shares Outstanding
343,933,313
Weighted Shares Outstanding
334,724,485
CEO
Christian P. Behrenbruch
Employees
554
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Telix Pharmaceuticals Limited American Depositary Shares Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...